Deep within nearly every cell in the body are tiny hair-like structures called cilia, and when the genes governing them malfunction, multiple organs can be affected at once — this is the foundation of a group of conditions known as ciliopathies, and Bardet-Biedl Syndrome (BBS) belongs to that group. Vision loss is one of its most consistent features, though it exists alongside a wider set of systemic findings that Nigerian families are typically already managing with local physicians before reaching out to us.
Because BBS affects so much of the body, our retinal evaluation is deliberately focused: we review existing records in advance to understand the broader systemic picture, then dedicate the in-person visit specifically to the eye testing and care planning that requires equipment most local clinics do not carry.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
“No — our evaluation and any retinal treatment remain focused specifically on the eye component. The other features of BBS, including weight management and kidney function, need to stay under the care of the relevant specialists, ideally with information shared between our team and theirs.”
”
In many cases, yes — central vision tends to be affected somewhat earlier in BBS compared with non-syndromic RP, which is a major reason we generally recommend closer monitoring intervals specifically for BBS patients.”
“Yes. Getting a baseline ERG and OCT done before symptoms appear makes it far easier to detect and measure change at future visits, and allows us to plan low-vision support proactively rather than reacting after the fact.”
“The fuller medical picture helps our team understand the whole context of the syndrome, even though the in-person visit itself stays focused specifically on retinal evaluation and care.”
